Publications by authors named "Simon Gunter"

Claim this Profile
O
Oligodendrocyte Slc48a1 (Hrg1) encodes a functional heme transporter required for myelin integrity.
John H Stockley, Adrien M Vaquie, Zhaoyang Xu, Theresa Bartels, Gregory D Jordan, Simon Gunter

Glia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Reactive Protein and Response to Adalimumab in Patients With Hidradenitis Suppurativa: A Post Hoc Analysis of 2 Randomized Clinical Trials.
Simon J Gunter, Martina L Porter, Alexa B Kimball

JAMA Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of care associated with utilization of telehealth in clinical trials.
Emily Gleason, Leslie Andriani, Elizabeth A Tubridy, Destiny Uwawuike, Simon Gunter

Gynecol Oncol Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials.
Simon J Gunter, Martina L Porter, Alexa B Kimball

Int J Womens Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab.
Simon J Gunter, Zachary E Holcomb, Barbara D Lam, Martina L Porter, Alexa B Kimball

JAMA Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome.
Simon J Gunter, Ellen J Kim

J Invest Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market dynamics of authorized generics in Medicaid from 2014 to 2020.
Benjamin N Rome, Simon J Gunter, Aaron S Kesselheim

Health Serv Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020.
Mayookha Mitra-Majumdar, Simon J Gunter, Aaron S Kesselheim, Beatrice L Brown, Krysten W Joyce

JAMA Netw Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicaid Spending on Drugs Marketed Without US Food and Drug Administration Approval in 2020.
Simon J Gunter, Aaron S Kesselheim, Benjamin N Rome

JAMA Intern Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market Exclusivity and Changes in Competition and Prices Associated With the US Food and Drug Administration Unapproved Drug Initiative.
Simon J Gunter, Aaron S Kesselheim, Benjamin N Rome

JAMA Intern Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis.
Nick G Cunniffe, Simon J Gunter, Michael Brown, Sarah W Burge, Clare Coyle

BMJ Open· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma.
Megan Wu, Jennifer Guan, Chris Li, Simon Gunter, Labeeba Nusrat

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratification bias in low signal microarray studies.
Brian J Parker, Simon Günter, Justin Bedo

BMC Bioinformatics· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis